Principal Investigator
Juan Alderuccio
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20241140
Clinical Trial Summary
Phase 2 Study of Epcoritamab in Combination with Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma
Phase
Phase II
Funding Agency/Sponsor
Institutional
Disease
Lymphoma
Contact Information
Phone Number
+1 (305) 2434624